Microscale porous membranes are used in a wide range of technical and medical applications such as water treatment, dialysis and in vitro test systems. A promising approach to control membrane properties and overcome limitations of conventional fabrication techniques is given by additive manufacturing (AM). In this study, we designed and printed a microporous membrane via digital light processing and validated its use for biomedical in vitro applications based on the example of a cell culture insert. A multi-layer technique was developed, resulting in an eight-layer membrane with an average pore diameter of 25 mm. Image analyses proved the printing accuracy to be high with small deviations for an increasing number of layers. Permeability tests with brilliant blue FCF (E133, triarylmethane dye) and growth factors comparing the printed to track-etched membranes showed similar transfer dynamics and confirmed sufficient separation properties. Overall, the results showed that printing microporous polymer membranes is possible and highlight the potential of AM for biomedical in vitro applications such as cell culture inserts, scaffolds for tissue engineering or bioreactors.
Introduction
Artificial microporous systems play an important role in many fields of technical and medical applications. 1 In food industries, membranes are used as ultrafiltration systems to eliminate microbes and enzymes, 2 for water treatment or desalination. 3, 4 In dialysis therapy, membranes are applied to remove substances by diffusion and filtration. 5 Further fields of application for membranes are in vitro test systems. 1 In tissue engineering, membrane-like scaffolds provide diffusive and structural properties guiding cell differentiation and organization. 6, 7 In co-culture approaches, membranes in cell culture inserts spatially separate cell fractions while allowing diffusion of proteins. 8, 9 Significant variations in pore size and pore density of these commercial membranes due to the fabrication process have been reported. 9 Microporous polymer membranes are commonly fabricated by phase inversion, track etching or electrospinning. The applied fabrication technique depends on the type of polymer and desired pore size and density.
Additive Manufacturing (AM) enables a high degree of freedom in design, and therefore the generation of structures, which could not or only at great cost be produced with common fabrication techniques up until now. 16 Especially for cell-based test systems the possibility of generating complex 3D channel networks is useful to add scaffold properties to a microporous membrane. 17, 18 The limitation of simultaneously controlling pore size, pore shape and pore distribution with conventional fabrication techniques can be overcome with AM. 19 Also, 3D-printing enables single-step fabrication reducing the risk of leakage, 14 malfunctions, potential contaminations and costs due to additional assembly steps.
To print microscale structures, mainly techniques based on photopolymerization such as digital light processing (DLP), stereolithography (SLA/m-SLA) or Two-Photon Photopolymerization (TPP) are used. 20 Resolutions down to 150 nm can be achieved with TPP. However, printers that use m-SLA or TPP technology are expensive and, due to the extremely fine resolution, the printing times are very high. 13, 20 DLP enables production of structures with resolutions down to 10 mm 20 having the advantage of using a UV-LED light source instead of a laser as in m-SLA, thus enabling polymerization of an entire layer in one step and a faster printing process. 21 Detailed reviews of current progress in the field of printing membranes including advantages and disadvantages of available printing techniques have been published recently. 13, 22 Reports of pore sizes achieved in membrane printing include a minimum pore diameter of 160 mm via fused deposition modeling (FDM) using polycaprolactone (PCL) 17 and 50-150 mm using a bio-ink. 18 A not further specified nozzle-based rapid prototyping technique using poly-lactate-acid (PLA) resulted in a pore size of 75 mm 23 and via DLP well resolved features in the range of 150-300 mm were printed using polydimethylsiloxane (PDMS). 24 For biomedical applications not only the resolution, but also biocompatibility of the printing material needs to be taken into account. 1, 25 Many bioprinting applications rely on FDM due to availability of bioink. 18 When printing with photopolymerization techniques, materials based on (meth)acrylates are state-of-the-art. However, the lack of biocompatibility of currently used (meth) acrylate-based polymers has been a drawback in printing of in vitro systems so far. 25, 26 Novel thiol-yne and (meth)acrylate-based photopolymers were established and positively evaluated for biocompatibility recently, which now makes DLP a promising printing technique for the production of cell-based medical devices. [27] [28] [29] As a result of the advances in AM, the drawbacks of currently used fabrication methods for polymer membranes and the increasing need for biomedical cell-based in vitro systems, the aim of our study was to demonstrate the suitability of AM for the creation of microporous membranes. Therefore, we developed a printed microporous polymer membrane directly integrated into a cell culture insert using DLP and evaluated its properties.
Materials and methods

Microporous membrane
The membranes were designed and converted into STL formats for the fabrication process using the CAD-software Catia 5.20 (Dassault Systemes, Ve´lizy-Villacoublay Cedex, France).
The membrane was assembled by multiple layers of strands meeting the resolution conditions (xy resolution: 50 mm, z resolution: 10-100 mm) of the printer Ember DLP SLA (Autodesk, Inc. San Rafael, USA) and taking sufficient handling into account. The strands of a single layer were equally aligned, whereas the orientation between the layers varied. The membrane was made up of eight layers reducing the final pore size with each additional layer. The layers consisted of strands with a height and width of 100 mm and distance of 150 mm. The overall height of the membrane was 800 mm. The first four layers were arranged in alternating angles of 0 , 90 and AE45 (see Figure 1 (a)) and followed by another four layers with the same alternating orientation; however, centering the strands between the strands of the previous equally aligned layer.
An open area throughout all layers of the membrane along the z-axis, not blocked by a strand of any layer, was defined as a continuous pore. The final pore size was stated by the continuous pores. With each additional and differently oriented layer, the final pore size of the continuous pores was reduced. The pore geometry of the final continuous pores resulted in a triangular shape with an average side length of 25 mm. The calculated size of a single continuous pore was 312.5 mm 2 with a pore density of 1.37 Â 10 3 pores per cm
0°0°F igure 1. Multi-layer design of the membrane (four of eight layers in a) and integration of the eight-layer membrane into a cylindrical frame (b). By changing the orientation of the printed strands in each layer, the size of the continuous pores and the total open pore area was reduced. By using this multi-layer technique, limitations of the DLP xy resolution were overcome.
For an application-oriented validation, the membrane was integrated into a cylindrical frame emulating commercially available cell culture inserts. The cylinder with a diameter of 8 mm and height of 12 mm was equipped with hangers for use in a 24-well microtiter plate (see Figure 1(b) ). The surface area of the membrane integrated in the cylindrical frame was 43 mm 2 resulting in a total open pore area of 0.184 mm 2 , defined by the continuous pores.
Printing was performed with the Autodesk standard clear prototyping resin (PR48) in a UV-shielded room. Post-processing consisted of cleaning the printed parts with 70% isopropanol, removing remaining residue in an ultrasound bath for 10 min at 40 kHz and curing in a UV chamber (CD-1 curing device, pro3dure medical GmbH, Dortmund, Germany) for 5 min. To make sure passage through the membranes was possible and the pores weren't closed, the permeability of isopropanol was tested in the cleaning process. The printed membranes were stored at room temperature between one day and several weeks prior to testing.
In the subsequent experiments, the printed membrane was compared to the commercially available cell culture insert ThinCert TM 1.0 mm (662610 Greiner Bio-One GmbH, Kremsmu¨nster, Austria). The integrated membrane was fabricated by ion etching, resulting in a pore diameter declared as 1 mm and density of 2 Â 
Technical validation
Process accuracy. The printing accuracy was evaluated using two simplified types of the designed multilayer membranes defined as validation membranes (VM). The strands of both membranes had a height and width of 100 mm. Validation membrane one (VM1) consisted of two layers with strands aligned in an angle of 0 and 90 . The distance between the strands and therefore the edge length of the quadratic pores was 300 mm. Validation membrane two (VM2) consisted of two additional layers of the same orientation. However, the strands of the third and fourth layer were centered between the strands of the previous layers of the same orientation, resulting in quadratic continuous pores with an edge length of 100 mm for VM2.
The VMs were analyzed with a digital light microscope (Keyence VHX 5000, VH-Z20T, Keyence, Osaka, Japan). Using the included image processing software (Keyence IV-H1, Keyence, Osaka, Japan), the geometry of the quadratic pores was measured. Ten membranes of each VM type were analyzed. Six adjacent continuous pores in five random positions of each sample were measured, resulting in a total of 300 measurement points for each VM type. The measured area of the pores was then compared to the pore area calculated based on the membrane design.
Equalization dynamics. The technical validation regarding permeability was performed with the eight-layer membrane integrated in a cylindrical frame for use as a cell culture insert (see Figure 1(b) ). The printed inserts were hung into a 24-well microtiter plate (4430300N, Orange Scientific) and filled with 250 ml of blue-dye reagent prepared by dissolving 0.15 g of brilliant blue FCF (Back-und Speisefarben, Dr. August Oetkar Nahrungsmittel KG, Bielefeld, Germany) into 10 ml of deionized water. The well compartments outside the inserts were then filled with 1.8 ml of clear deionized water ensuring an equal liquid level and preventing a pressure driven transfer of the liquids through the insert membrane. The permeability properties were quantified by obtaining the period of time needed for equalization of the two liquids' color strength and comparing the equalization dynamics of the change in color strength with the commercial cell culture inserts ThinCert TM 1.0 mm. In Figure 2 , different degrees of equalization during the permeability experiments are shown. Duplicate samples of 75 ml were taken at fixed times between 10 min and 24 h from each well compartment outside the inserts and replenished with 150 ml of deionized water to regain the initial liquid level after each sampling step. Sampling was to be performed with great care as not to influence the equalization dynamics by removing liquid too quickly. The samples were collected in a 96-well microtiter plate, and the color strength was measured with a photometer (MultiskanTM FC, Thermo Fisher Scientific Inc., Waltham, USA) at a wavelength of 620 nm.
Application-oriented validation
The evaluation of the proliferative effect of growth factors released from blood platelets is an application of cell culture inserts, 30 which is also used in our lab. In this area of application, a platelet-rich blood derivative is separated from cell culture medium by the membrane of the insert, which holds the blood cells back but lets the growth factors pass. We validated our membrane for this biomedical in vitro application by using platelet rich plasma (PRP) as the source of growth factors. Generation of PRP was carried out with a fully automated centrifugation system from 11 ml of whole blood drawn from healthy donors as previously described. 31 Adhesion of thrombocytes. To determine the integrity of the platelets and the ability to release growth factors, the adhesion of thrombocytes onto the printed membrane was tested. The eight-layer membrane was printed into a cylindrical frame with a height of 3 mm and covered with 100 ml of PRP. After an incubation time of 1 h at room temperature during which platelet adhesion on the membrane structures and activation took place the membranes were prepared for investigation in a scanning electron microscope (JSM 6390, Jeol GmbH, Freising, Germany) by fixing with glutaraldehyde and an ascending alcohol series.
A critical point dryer (CPD 030, Bal-Tec AG, Balzers, Liechtenstein) was then used for the drying process followed by sputtering the membranes at 40 mA for 40 ms with a 7 nm gold coating (Coating System MED 020, Bal-Tec AG, Balzers, Liechtenstein).
Growth factor permeation. To test the possible use of the membrane in co-incubation experiments with plateletrich blood derivatives, we determined the dynamics of growth factor permeation through the printed membrane into cell culture medium. We compared the printed cell culture inserts to commercial inserts with track-etched membranes (ThinCert TM 1 mm). Both types of inserts were placed into a 24-well microtiter plate and filled with 250 ml of PRP. The well compartments outside of the inserts were then filled with 1.8 ml of cell culture medium DMEM (FG 0435, Biochrom GmbH, Berlin, Germany). Two hundred fifty microliters were sampled from the well compartments outside of the inserts at different time points between 1 h and 14 days and stored at À20
C. The removed sample volume was replenished with cell culture medium to maintain an equal liquid level.
PDGF was chosen as the growth factor representative and detected in the samples via ELISA (PDGF-AB Duoset DY222, R&D Systems, Minneapolis, USA). The colorimetric analysis was performed with a photometer (Multiskan TM FC, Thermo Fisher Scientific Inc., Waltham, USA) at 450 nm and 620 nm. The detected amount of PDGF was calculated as release per platelet and the number of platelets in the PRP was detected with a hematology analyzer (Sysmex KX-21N, Sysmex GmbH, Norderstedt, Germany).
Results
Printed porous membrane
The eight-layer porous membrane was printed into two types of frames. Figure 3 shows the membrane in a frame with a height of 3 mm (2) for analysis in a scanning electron microscope and in a frame with a height of 12 mm (3) for use as a cell culture insert compared to the commercially available ThinCert TM inserts (1). An optical inspection was performed after every printing job to evaluate the quality of the membranes. The membranes were only used for the following validation experiments if no broken or distorted strands were detected. The success rate of each printing job defined by the number of successfully printed faultless membranes varied between 50% and 80%.
For a cost-benefit estimation of the printed membrane compared to the commercial membrane, the machine costs (3D-printing vs. track-etching) and the material costs (biocompatible photopolymer vs. polyethylene terephthalate (PET)) were taken into account. When comparing the printed and commercial (ThinCert   TM   ) cell culture inserts, the number of process steps (1 vs. 3) must also be considered due to injection molding of the housing with polystyrene (PS) and additional assembly step for the commercial inserts.
The biocompatible printing material costs 290 e per kg. At a weight of 0.3 g per printed insert, 3000 pieces, considering 10% buffer for material residue and support structures, can be printed per kg resulting in material costs of 0.10 e per piece. Purchase costs for a DLP printer vary between 5000 e and 15,000 e and the printing time, depending on the number of layers, for our developed inserts was 1 h. The printable amount of inserts in this time is limited by the size of the printer's building platform. With our printer (Ember DLP), 12 inserts were printed in a single job.
Production of the commercial inserts is executed via injection molding, track-etching and assembly of the housing and membrane, resulting in a purchase price of 4.80 e per ThinCert TM insert in a 48 piece unit. The number of processing steps, processing costs, machine and tooling costs are therefore much higher. Material costs of the commercial inserts (industrial grade PS and PET 0.5-1 e per kg, medical grade multiplier Â 30-50) are lower at the moment. However, we expect costs for biocompatible printing materials to significantly decrease in the near future, due to increasing development and use. The cost-benefit ratio of our printed membrane will therefore further improve.
Technical validation
Process accuracy and pore size. The pore area of the twolayer and four-layer VM was each evaluated with 300 measuring points. The evaluation method is illustrated in Figure 4 by framing the resulting pores with black squares in the two-layer (a: VM1) and with white squares in the four-layer (b: VM2) VM.
In Table 1 , the designed (calculated) and analyzed pore sizes are compared. The analyzed pore area of the printed two-layer membrane (VM1) was 23.1% larger than the calculated value, corresponding with an 11% increased edge length. The printed four-layer membrane (VM2) resulted in an actual pore area 4.7% larger than the design, corresponding with a 2% increased edge length.
Equalization dynamics. The printed eight-layer membrane fulfilled the usability requirement of a cell culture insert by initially separating the test liquids (blue dye reagent and clear water) followed by an equalization process over time (24 h ), as observed with commercial inserts. The photometric results of the permeability experiments with 9 printed and 3 commercial (track-etched) cell culture inserts are illustrated in Figure 5 . The printed and track-etched membranes showed a comparable steady increase of color strength due to permeation of the blue dye reagent. However, the deviation between the printed membranes was very high. Equalization of the blue dye and clear water was detected after 24 h for the track-etched membranes and 2 printed membranes. The remaining printed membranes showed altering equalization dynamics including: delayed equalization reaching only half of the equilibrium after 24 h (n ¼ 2), accelerated equalization (n ¼ 3), already reaching the equilibrium after 3 h and increased permeation of blue dye up to the 2 h measurement point, yet not fully reaching the equilibrium after 24 h (n ¼ 2). A further measurement at 48 h resulted in detection of the equilibrium for all printed membranes.
Further 15 printed membranes were tested with altered experimental parameters and therefore not included in the displayed results. The continuous increase in color strength towards the equilibrium was confirmed for all tested membranes.
Application-oriented validation
Adhesion of thrombocytes. Using scanning electron microscopy, the distribution of blood cells on the eight-layer membrane was investigated (Figure 6 (a) to (c)) and compared to the commercial track-etched membrane ( Figure 6(d) ).
In the SEM studies, the top two layers of the printed membrane are visible with aggregated blood cells in the pores (Figure 6(a) ). The aggregates mainly consist of erythrocytes and fill out the pores (Figure 6(b) ). At 1500 Â magnification, individual thrombocytes are visible ( Figure 6(c) ). The platelets adhered to the strands and are in an activated state as can be seen by the formation of pseudopodia. The membrane of the commercial ThinCert TM inserts is displayed at the same magnification (1500Â) without blood cells (d). The random distribution of the 1 mm sized pores produced by an etching process is visible. After contact with blood the pores of the track-etched membrane were covered with blood cells and only a few pores were visible due to their small size.
Growth factor permeation. The final application-oriented validation test was performed with 21 membranes printed in two batches and PRP from two donors. An optimization of the parameter settings of the UVlight exposure (height of the curing layers and light intensity) during the printing process affected the quality of the membranes, and the success rate between printing batch 1 and 2 was improved. The amount of PDGF released from the thrombocytes was measured in the cell culture medium and therefore marked Figure 5 . Equalization process of blue dye reagent and clear water separated by printed membranes and commercial tracketched membranes. The degree of equalization increased over time for all printed membranes and is comparable to the tracketched reference group. High deviations between the printed membranes due to delayed equalization (n ¼ 2) and accelerated permeation (n ¼ 5) were detected. Simultaneous equalization with the reference group after 24 h was also observed (n ¼ 2). The equilibrium was reached after 48 h at the latest for all printed membranes.
the amount of growth factors transferred through the membrane. The results of the growth factor permeation from the PRP of donor 1 (1732 Â 10 3 plt/ml) through six membranes printed in batch 1 are displayed in Figure 7 and compared to the results of the commercial track-etched membrane. Using the commercial inserts (TC) resulted in a continuous increase of PDGF in the cell culture medium up to 4500 pg/ml after 14 days of incubation. Six printed membranes (M1-M6) showed a comparable increase resulting in a maximum after 14 days varying between 830 pg/ml and 7950 pg/ml. After up to 24 h, nearly no PDGF was detected confirming the passage of growth factors from the PRP into the cell culture medium over time. The samples were additionally checked for passage of blood cells with a hematology analyzer and no blood cells were detected indicating a sufficient separation of the PRP from the cell culture medium by the printed membranes.
The remaining 7 of 13 printed membranes in batch 1 did not match the continuous increase of PDGF over time as measured with the commercial membrane. PDGF values between 3000 pg/ml and 10,000 pg/ml were detected in the 1 h samples indicating an immediate transfer of PDGF into the cell culture medium. The values remained constant over the whole experiment and only slightly increased or even decreased. Despite the high amount of PDGF detected in the divergent samples, a detectable passage of blood cells of 2-17 Â 10 3 plt/ml was determined only for 3 membranes. However, an error of AE10 Â 10 3 plt/ml in the detection limit of the hematology analyzer is stated in the manufacturer's specification.
Growth factor permeation of PDGF into cell culture medium through 8 membranes printed in batch 2 was investigated with PRP from donor 2 (2918 Â 10 3 plt/ml) and compared to the commercial inserts. The PDGF values in the cell culture medium after passage through 4 printed membranes (M1-M4) and the track-etched commercial membrane (TC) are illustrated in Figure 8 . At all sampling times, the measured values of the printed membranes (M1-M4) were very close to the reference values of the track-etched membrane (TC). A continuous increase of the PDGF values up to 5200 pg/ml was detected in the 14 day samples of the reference and the printed membranes resulted in values between 3530 pg/ml and 5100 pg/ml. No blood cells were detected in the samples confirming the sufficient separation of PRP and cell culture medium by the printed membranes.
Due to optimization of the parameters during UV exposure concerning the height of the curing layers and light intensity, the quality of the membrane was improved between printing batch 1 and 2. Only one membrane from batch 2 resulted in an immediate passage of PDGF with a value of 12,100 pg/ml in the 1 h sample. This was also the only sample with a detectable passage of blood cells of 4 Â 10 3 plt/ml. Three of the remaining 4 membranes printed in batch 2 showed an increase in PDGF permeation over time, yet with fluctuating PDGF values over the course of the experiment.
To confirm the accuracy of the results and for better comparability, the stated PDGF values were calculated as the release per platelet using the platelet count of the PRP. As a point of reference, the physiological value of PDGF is 60 pg/10 6 platelets 32 with a physiological donor dependent deviation. The maximum values reached in our experiments were 64 pg/10 6 platelets for donor 1 and 71 pg/10 6 platelets for donor 2 in samples from membranes with insufficient initial separation properties resulting in immediate passage of PDGF. The calculated amount of PDGF released per platelet and transferred though the track-etched membranes after 14 days was 23.41 pg/10 6 platelets for donor 1 and 16.04 pg/10 6 platelets for donor 2. The values reached with the printed membranes displayed in Figures 7 and 8 after 14 days corresponded with a release per platelet of 4-41 pg/10 6 platelets for donor 1 and 11-34 pg/10 6 platelets for donor 2.
Discussion
Our work showed that it is possible to print microporous polymer membranes for cell-based applications using a multi-layer technique overcoming the resolution limitations towards single-layer membranes of digital light printers. In contrast to conventional generation techniques for microporous membranes (e.g. phase inversion, track etching or electrospinning), it is possible to achieve evenly distributed pores of definable and reproducible size by 3D-printing. With our multi-layer technique, continuous triangular pores with an average side length of 25 mm were achieved by decreasing the continuous pore size layer by layer.
Multi-layer technique
A characteristic feature of the presented multi-layer technique is the resulting large surface to volume ratio within the pore system. The multi-layer technique is therefore advantageous for all membrane applications in need of a large reaction surface and for filtering applications based on the adherence of particles. In cell-based applications, the possibility of cells adhering to the 3D membrane structures simultaneously allowing diffusion of substances is of interest (e.g. coincubation approaches) and distinguishes the printed membranes from conventional single-layer membranes. Additionally, the multi-layer technique could be useful for overcoming the resolution limitations of other printing technologies.
Printing process and accuracy
To realize microporous polymer membranes with 3D-printing, the printing process needs to be highly accurate and the designed model needs to be implemented without deviation. Deviations due to limited accuracy and reproducibility of the printing process were a challenge in developing the microporous membrane in this study. Numerous failed printing attempts due to broken strands, distorted strands or closed membranes resulted in rejects and demonstrated limited reproducibility. Another observed fault was the cracking of the printed strands due to aging effects of membranes stored for more than a week prior to testing. We attributed this effect to remnants of liquid resin due to insufficient cleaning, and we improved the long-term stability by treating the printed membranes with isopropanol (70%) in an ultrasonic bath directly after printing.
The printing accuracy was validated by printing two-layer and four-layer VMs and analyzing the pore size with a digital microscope. Due to the limited depth of field of the accessible microscope, it was not possible to measure the pores of the final eight-layer membrane. The actual printed pore size of the two-layer membrane was 23% larger than the design with a deviation of 5.6% in the measurements. We correlated the increased pore size to a decline in the width of the membrane strands. The printed pores of the four-layer membrane only increased by 6% towards the design; however, a deviation of 12.6% was calculated between the measurements. An increase in the number of layers resulted in a higher accuracy of the printed pores when compared with the design. However, the higher deviation between the measurements implied a reduced reproducibility in the printing process. This leads to the assumption that, with each added layer, variations in the pore size increase and complicate the adjustment of defined pore sizes. Yet, with an improved and more accurate printing process, the pore size could be further reduced by adding additional layers to the design. For a quantitative investigation of the final pore size of membranes with an increased number of layers, including our final eight-layer membrane, a microscope with a higher depth of field should be used.
Open pore area. The open pore area is a very important characteristic of our developed membrane as it states the total area of passage. The calculation of the open pore area for our printed membranes was based on the pore size of the continuous pores. The membrane was therefore idealized as a one-layer membrane by infinitely reducing the thickness of each layer. The open pore area was then calculated with the final pore size, pore density and area of the membrane resulting at 0.184 mm 2 . The pore area of the ThinCert TM inserts was calculated at 0.528 mm 2 due to the manufacturer's specifications. This calculation resulted in an almost threefold open pore area for the single-layer tracketched membrane indicating a larger area of passage. However, growth factors and other elements not only pass the multi-layer membrane vertically, via the continuous pores, but can also travel diagonally between layers and interconnected pores. Thus, the actual area of passage of the printed membrane is larger than calculated with the single-layer idealization and is actually closer to the area of passage of the track-etched membrane. To verify this assumption, we conducted validation experiments comparing our printed cell culture inserts (eight-layer membrane) to the commercial ThinCert TM inserts (track-etched membrane).
Equalization dynamics. Testing the equalization dynamics of a brilliant blue FCF reagent separated from clear water by the membranes aimed at confirming a comparable area of passage between our printed and the track-etched membranes. We assumed that a larger open pore area would lead to an immediate passage of the blue dye reagent followed by an accelerated equalization process. The results showed that a sufficient and comparable pore size and area of passage had been achieved due to successful separation of the liquids. In all tested membranes, an increase in color strength showing permeability over a comparable period of time was detected. However, variations between the printed membranes were very high, indicating varying open pore areas. The variations of the pore size and pore area in the printed membranes were confirmed both by an accelerated and delayed equalization, indicating a larger and smaller pore area, respectively. Although sampling was performed with great care, an influence on the equalization dynamics could not be excluded. If the samples were drawn too quickly, an increase in the color strength was observed which might have additionally increased the deviations.
Application-oriented validation
For validation of the printed eight-layer membrane as a cell culture insert, an application-oriented method was prepared. Co-culture systems are successfully used to detect the influence of growth and differentiation factors on cells spatially separated by membranes. The requirements for the inserts are prevention of cell passage through the membrane whilst enabling diffusion of proteins. In the specific application of investigating the proliferative effects of growth factors released from blood platelets, a platelet-rich blood derivative is separated from cells (cell culture medium) by the membrane. The pores of the tracketched membrane in the commercial ThinCert TM inserts with a diameter of 1 mm are smaller than thrombocytes (diameter 2-5 mm
33
) preventing passage of blood cells whilst enabling diffusion of growth factors. A drawback of the track-etched membrane is the possibility of pores being blocked by erythrocytes with an average diameter of 7 mm, which is a common problem of membranes in blood contact 1 and can impede growth factor permeation in our specific application. Growth factors are stored in thrombocytes and released upon activation, 34 which is induced by contact with any foreign material 35 upon adhesion of the thrombocytes. The large contact area of our printed multi-layer membrane is advantageous towards commercial single-layer membranes for activation of thrombocytes. However, the final pores with a diameter of 25 mm are larger than blood cells and passage of blood cells is possible. SEM analyses and detection of growth factor permeation were performed to analyze the membrane properties for this application.
Adhesion of thrombocytes. By studying the morphology of the platelets adhered to the strands of our final printed eight-layer membrane via SEM analysis, an activated state was determined and release of growth factors was assumed. Additionally, the pictures showed that the blood cells formed aggregates in the pores and seemed to block the passageway for blood cells through the printed membrane. This was confirmed by the results of the hematology analyzer detecting no cells in samples drawn in a two-week time span.
Growth factor permeation. The amount of growth factors released into cell culture medium through the tracketched and printed membranes in a period of two weeks was evaluated. The results of the amount of PDGF detected in the medium and therefore passed through the membranes stated the quality of the printed membranes for co-culture applications. A steady increase nearly indistinguishable from the track-etched membrane was detected for membranes printed with optimized UV-curing parameters. The variations of the PDGF values between the membranes, especially printed before further parameter optimization were related to the variations of the pore size. The growth factor permeation approach proved to be an accurate and appropriate method to test the co-incubation properties of the printed membrane. If the printed membranes had faults, an increased release of PDGF was detected. Higher PDGF values with a continuous increase over time indicated a higher degree of thrombocyte activation, which could also be correlated to the larger surface of the printed multi-layer membrane compared to the single-layer track-etched membrane. Broken membranes with passage of blood cells detected in the hematology analyzer resulted in a steady PDGF value throughout the experiment. Closed membranes resulted in no detection of PDGF. Printing with a biocompatible material will make testing of the proliferative effect on fibroblasts possible and finally prove our printed microporous membrane as an application possibility for biomedical in vitro systems. Furthermore, it was demonstrated that, by optimizing the printing parameters (UV-curing), the accuracy of the printing process was improved. The membrane design is effective and needs to be printed without deviation.
Although the printing material used in this study does not fulfill the biocompatibility requirements for cell-based applications, we expect the membrane properties and experimental results not to be significantly changed when using a biocompatible resin. This assumption is underlined by current DLP printing trials in our lab with a biocompatible resin showing very similar printing properties to the resin used in this study.
Conclusion
In this study, we successfully printed a microporous polymer membrane with an average pore size of 25 mm. To overcome the limited xy resolution of digital light printers in the micrometer scale, we introduced a multi-layer technique. With each layer, the pore size was reduced and the surface-to-volume ratio increased. Advancements in printing technology will make even further pore size reduction of the presented 25 mm possible. An application-oriented validation was performed by printing the developed eight-layer membranes as cell culture inserts and comparing the properties to commercial ThinCert TM inserts with track-etched membranes. The equalization dynamics were comparable and the amount of PDGF transferred through the membrane was nearly indistinguishable from the track-etched membranes. SEM pictures of blood cells on the membrane showed aggregates in the pores preventing passage of blood cells. Improved accuracy of 3D-printers and biocompatible printing materials suggest our printed porous membrane as a promising tool for a wide range of applications.
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